Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LUNGevity Foundation Unites Communities to Advance Progress During 2026 Lung Cancer Awareness Month

prnewswire.com
AZN AstraZeneca is listed as a Platinum Sponsor for LUNGevity Foundation's Lung Cancer Awareness Month, showing support for the cause without direct commentary on the company's performance. JNJ Johnson & Johnson is mentioned as a Platinum Sponsor for LUNGevity Foundation's Lung Cancer Awareness Month, indicating support for the cause but not direct company performance. AMGN Amgen is identified as a Gold Sponsor for LUNGevity Foundation's Lung Cancer Awareness Month, signifying support for the initiative rather than company-specific news. LLY Eli Lilly is listed as a Silver Sponsor for LUNGevity Foundation's Lung Cancer Awareness Month, indicating support for the cause but not direct company performance. MRK Merck is identified as a Silver Sponsor for LUNGevity Foundation's Lung Cancer Awareness Month, signifying support for the initiative rather than company-specific news. REGN Regeneron is listed as a Silver Sponsor for LUNGevity Foundation's Lung Cancer Awareness Month, showing support for the cause without direct commentary on the company's performance.

LUNGevity Foundation Unites Communities to Advance Progress During 2026 Lung Cancer Awareness Month Throughout November, LUNGevity will mobilize communities nationwide to support research, expand awareness of early detection, and improve the lives of people affected by lung cancer.

WASHINGTON, Nov. 2, 2026 /PRNewswire/ -- This November, LUNGevity Foundation will bring communities across the country together for Lung Cancer Awareness Month (LCAM), turning awareness into action through public installations, community events, education, and advocacy to advance progress against lung cancer.

Lung cancer remains the leading cause of cancer death in the United States, but advances in early detection, precision medicine, and treatment are helping people live longer and better. This progress offers real hope and underscores the importance of making new advances accessible to everyone who needs them. Too many people are still diagnosed after their cancer has spread, while misconceptions and stigma can stand in the way of informed conversations about the disease. Continued research, earlier detection, and better access to care are essential to saving more lives.

"Lung Cancer Awareness Month is a time to recognize how far we have come and what we can accomplish together," said Andrea Ferris, President and CEO of LUNGevity Foundation. "Research is improving how we detect and treat lung cancer, and earlier detection can save lives. Our responsibility now is to build on that progress and make sure more people benefit from it. We invite communities across the country to join us in advancing research, expanding access to care, and improving lives."

Throughout November, LUNGevity will offer opportunities for people across the country to learn, connect, and make a difference, including:

Across these initiatives, LUNGevity is focused on a clear goal: ensuring that progress in lung cancer research and care accelerates and reaches more people. Scientific advances are creating new opportunities to detect lung cancer earlier and treat it more effectively. Greater awareness can challenge stigma and encourage timely conversations about screening and care. By working together, patients, survivors, caregivers, advocates, researchers, healthcare professionals, and supporters can help accelerate progress and improve lives.

LUNGevity's Lung Cancer Awareness Month initiatives are made possible with support from Presenting Sponsor Boehringer Ingelheim; Platinum Sponsors AstraZeneca and Johnson & Johnson; Gold Sponsor Amgen; and Silver Sponsors Daiichi Sankyo, Genentech, Lilly, Merck, Nuvalent, Regeneron, and Takeda.

Their support helps extend awareness, education, research, and community engagement throughout November and beyond.

Together, LUNGevity and the lung cancer community are advancing a future in which lung cancer is detected earlier, treated more effectively, and ultimately cured.

Visit www.LUNGevity.org/LCAM to learn more and find ways to get involved in Lung Cancer Awareness Month.

About LUNGevity Foundation

LUNGevity Foundation is transforming what it means to be diagnosed and live with lung cancer. While many organizations focus on one aspect of lung cancer, LUNGevity works across research, advocacy, and patient support, because lasting progress requires connecting all three.

As the largest nonprofit funder of lung cancer research in the United States, LUNGevity drives progress in early detection, more effective treatments, and the next generation of researchers. We empower people diagnosed with lung cancer and their caregivers with scientifically vetted information, resources, and community and advocate for policies that improve access to screening, biomarker testing, treatment, and high-quality care for all.

By connecting scientific discovery, patient experience, and advocacy, we help ensure research reflects what patients need, breakthroughs reach the people who can benefit from them, and patient voices help drive meaningful change.

Our vision is a world where no one dies of lung cancer.

Please visit www.LUNGevity.org to learn more.

About Lung Cancer in the US

SOURCE LUNGevity Foundation